XML 60 R43.htm IDEA: XBRL DOCUMENT v3.20.4

SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

12 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

Schedule of Net Sales and Profit, by Segment

Net sales and profit by reportable segment for the years ended December 31, 2020, 2019 and 2018 are as follows:

			Years Ended December 31,
			2020						2019						2018
			(In thousands)
Segment Net Sales
Codman Specialty Surgical			$	894,831					$	996,206					$	963,929
Orthopedics and Tissue Technologies			477,037						521,351						508,512
Total revenues			$	1,371,868					$	1,517,557					$	1,472,441
Segment Profit
Codman Specialty Surgical			$	356,657					$	395,019					$	363,336
Orthopedics and Tissue Technologies			159,630						144,638						149,510
Segment profit			516,287						539,657						512,846
Amortization			(27,757)						(27,028)						(21,160)
Corporate and other			(337,160)						(418,869)						(380,688)
Operating income			$	151,370					$	93,760					$	110,998

Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:

			United States*						Europe						Asia Pacific						Rest of the World						Consolidated
			(In thousands)
Total revenue, net:
2020			$	971,975					$	172,689					$	157,174					$	70,030					$	1,371,868
2019			1,077,379						197,468						157,391						85,319						1,517,557
2018			1,045,887						201,354						144,253						80,947						1,472,441
Total long-lived assets:
2020			$	324,893					$	38,812					$	13,121					$	5,577					$	382,403
2019			383,652						47,325						8,598						7,143						446,718

* Includes long-lived assets in Puerto Rico.

Schedule of Geographic Revenue, by Area

Net sales and profit by reportable segment for the years ended December 31, 2020, 2019 and 2018 are as follows:

			Years Ended December 31,
			2020						2019						2018
			(In thousands)
Segment Net Sales
Codman Specialty Surgical			$	894,831					$	996,206					$	963,929
Orthopedics and Tissue Technologies			477,037						521,351						508,512
Total revenues			$	1,371,868					$	1,517,557					$	1,472,441
Segment Profit
Codman Specialty Surgical			$	356,657					$	395,019					$	363,336
Orthopedics and Tissue Technologies			159,630						144,638						149,510
Segment profit			516,287						539,657						512,846
Amortization			(27,757)						(27,028)						(21,160)
Corporate and other			(337,160)						(418,869)						(380,688)
Operating income			$	151,370					$	93,760					$	110,998

Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:

			United States*						Europe						Asia Pacific						Rest of the World						Consolidated
			(In thousands)
Total revenue, net:
2020			$	971,975					$	172,689					$	157,174					$	70,030					$	1,371,868
2019			1,077,379						197,468						157,391						85,319						1,517,557
2018			1,045,887						201,354						144,253						80,947						1,472,441
Total long-lived assets:
2020			$	324,893					$	38,812					$	13,121					$	5,577					$	382,403
2019			383,652						47,325						8,598						7,143						446,718

* Includes long-lived assets in Puerto Rico.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration